STOCK TITAN

Cbdmd Stock Price, News & Analysis

YCBD NYSE

Company Description

Company Overview

cbdMD, Inc. (YCBD) is a U.S.-based specialty company that produces and distributes premium hemp-derived cannabidiol (CBD) products combined with innovative functional mushroom supplements. Established in 2015 and headquartered in Charlotte, North Carolina, the company has cultivated a diverse portfolio that caters to both individual and pet wellness. Its key brands, including cbdMD, Paw CBD, and ATRx Labs, exemplify its dedication to natural health solutions backed by stringent quality standards and science-based research.

Business Model & Distribution

Operating in the dynamic wellness and cannabinoid industries, cbdMD, Inc. employs a multi-channel distribution strategy that drives revenue through a variety of platforms. The company leverages its flagship e-commerce website along with third-party online retail sites, wholesalers, and brick-and-mortar retailers. This extensive distribution network not only enhances market reach but also positions the business to address the increasing consumer demand for U.S.-produced, THC-free CBD and related wellness products.

Product Portfolio & Innovation

The product lineup of cbdMD, Inc. is comprehensive and varied, designed to meet a broad spectrum of consumer needs. The core offerings under the cbdMD brand include CBD tinctures, gummies, topicals, capsules, bath products, and sleep aids that have been formulated to provide relief and enhance overall well-being. The Paw CBD brand extends the company's expertise to pet wellness with veterinarian-formulated tinctures, chews, and topicals tailored for various pet health requirements.

In addition to its established CBD offerings, the company has diversified its product base with the ATRx Labs brand. This division focuses on functional mushroom supplements that harness the benefits of natural extraction and modern formulation techniques. These supplements are designed to support cognitive function, immune response, and overall health, integrating naturally derived ingredients to appeal to wellness enthusiasts who seek alternatives to traditional products.

Market Position & Industry Expertise

In an industry that demands both innovation and compliance, cbdMD, Inc. stands out through its commitment to product quality and scientific integrity. The company adheres to stringent manufacturing standards in line with Farm Bill regulations, ensuring all its products are THC-free and safe for consumption. It incorporates advanced extraction methods and clinical research to validate the efficacy of its formulations, thereby building a reputation grounded in transparency and trustworthiness.

Operational Strategy & Competitive Advantages

  • Multi-Channel Distribution: A vast network including its own e-commerce platform, third-party websites, and physical retail locations ensures extensive market penetration.
  • Science-Backed Formulations: Products are developed using rigorous research and clinical trial data that support claims of safety and effectiveness.
  • Innovative Product Development: Continuous investment in R&D allows the company to diversify its product portfolio and respond to emerging consumer trends.
  • Quality and Regulatory Compliance: The company’s commitment to producing THC-free, Farm Bill-compliant products is central to its value proposition.
  • Operational Efficiency: Strategic cost management and expense optimization reflect the company’s focus on enhancing its operational stability without compromising product quality.

Consumer & Investor Considerations

cbdMD, Inc. prioritizes consumer safety and product efficacy through stringent quality control measures and adherence to relevant regulatory standards. By blending traditional wellness practices with modern scientific advancements, the company delivers products that are not only innovative but also reliable. Investors and market analysts can view cbdMD, Inc. as a noteworthy example of a business that combines diversified revenue streams, a broad product portfolio, and a commitment to quality—and scientific validation—to build trust and stakeholder confidence.

Conclusion

Overall, cbdMD, Inc. is positioned as a comprehensive provider of premium CBD and functional wellness solutions. Through a robust operational framework, multi-channel distribution, and a steadfast commitment to quality and research, the company continues to build an enduring legacy in the competitive wellness market. Its systematic approach to innovation and operational integrity makes it a key subject of interest for in-depth investment research and market analysis.

Stock Performance

$0.2500
-4.91%
0.01
Last updated: April 25, 2025 at 17:54
-61.83 %
Performance 1 year
$1.4M
Market Cap
6.3M
Shares outstanding

SEC Filings

No SEC filings available for Cbdmd.

Financial Highlights

$5,113,476
Revenue (TTM)
$15,095
Net Income (TTM)
0.30%
Net Profit Margin
-1.69%
Oper. Profit Margin
66.50%
Gross Profit Margin
0.69
Current Ratio

Upcoming Events

Frequently Asked Questions

What is the current stock price of Cbdmd (YCBD)?

The current stock price of Cbdmd (YCBD) is $0.2629 as of April 25, 2025.

What is the market cap of Cbdmd (YCBD)?

The market cap of Cbdmd (YCBD) is approximately 1.4M.

What is the revenue (TTM) of Cbdmd (YCBD) stock?

The trailing twelve months (TTM) revenue of Cbdmd (YCBD) is $5,113,476.

What is the net income of Cbdmd (YCBD)?

The trailing twelve months (TTM) net income of Cbdmd (YCBD) is $15,095.

What is the profit margin of Cbdmd (YCBD)?

The net profit margin of Cbdmd (YCBD) is 0.30%.

What is the operating margin of Cbdmd (YCBD)?

The operating profit margin of Cbdmd (YCBD) is -1.69%.

What is the gross margin of Cbdmd (YCBD)?

The gross profit margin of Cbdmd (YCBD) is 66.50%.

What is the current ratio of Cbdmd (YCBD)?

The current ratio of Cbdmd (YCBD) is 0.69, indicating the company's ability to pay short-term obligations.

What is the gross profit of Cbdmd (YCBD)?

The gross profit of Cbdmd (YCBD) is $3,400,609 on a trailing twelve months (TTM) basis.

What is the operating income of Cbdmd (YCBD)?

The operating income of Cbdmd (YCBD) is -$86,272.

What type of products does cbdMD, Inc. offer?

cbdMD, Inc. offers a broad range of hemp-derived CBD products including tinctures, gummies, topicals, capsules, pet products, and functional mushroom supplements.

Which brands are operated by the company?

The company operates the cbdMD and Paw CBD brands for its CBD offerings and the ATRx Labs brand for its functional mushroom products.

How does the company distribute its products?

Products are distributed through the company’s e-commerce website, third-party online retailers, wholesalers, and traditional brick-and-mortar retail outlets across the United States.

What makes cbdMD, Inc. distinctive in the wellness market?

Its focus on science-backed product development, adherence to strict quality standards, and a diversified product portfolio in both CBD and functional mushroom segments distinguish cbdMD, Inc. in the competitive wellness market.

How does cbdMD ensure the safety and quality of its products?

The company follows rigorous manufacturing processes and quality control measures in compliance with Farm Bill regulations, ensuring that all products are THC-free and meet high safety standards.

What consumer segments does the company target?

cbdMD, Inc. targets wellness enthusiasts, pet owners, and consumers seeking natural health supplements and alternatives through both cannabinoid and functional mushroom products.

How is the company innovating in the CBD space?

Innovation is driven by continuous research and development efforts, including clinical trials and advanced formulation techniques that yield new products to meet diverse consumer health needs.

What advantages does the company have in the market?

Its multi-channel distribution, strong research foundation, commitment to quality, and ability to adapt to changing consumer trends provide cbdMD, Inc. with a competitive edge in the industry.